Alzheimer's disease (AD) is a neurodegenerative disease that is characterized by the
production and deposition of β-amyloid protein (Aβ) and hyperphosphorylated tau, leading …

Differentiation of oligodendrocyte precursor cells (OPCs) into mature oligodendrocytes (OLs)
is a key event for axonal myelination in the brain; this process fails during demyelinating …

Brain photobiomodulation (PBM) is an innovative treatment for a variety of neurological
conditions, including cerebral ischemia. However, the capability of PBM for ischemic stroke …

There is growing interest in understanding how ethanol use interacts with advancing age to
influence the brain and cognition. Animal models are employed to investigate the cellular …

Chronic treatment with serotonin selective reuptake inhibitors or tryciclic antidepressant
drugs in rodents has been shown to increase the expression of GluA1 and/or GluA2 AMPA …

Chronic ethanol exposure (CEE) is associated with greater neurodegenerative effects and
an increased risk of depression disorder. The AMPAR is thought to be involved in …

Background Prenatal alcohol exposure (PAE) induces a wide range of neurodevelopmental
disabilities that are grouped under the term 'fetal alcohol spectrum disorders'(FASD). The …

Background: We recently demonstrated that oxygen-glucose deprivation (OGD) and
unconjugated bilirubin (UCB) can damage mature and immature organotypic hippocampal …

Prenatal alcohol exposure (PAE) affects neuronal networks and brain development causing
a range of physical, cognitive and behavioural disorders in newborns that persist into …

Background: Alcohol use disorder (AUD) is characterized by chronic excessive alcohol
consumption, often alternating with periods of abstinence known as alcohol withdrawal …